风湿性二尖瓣术后主动脉瓣病变进展的转归
该研究纳入1155例1997至2015年接受风湿性二尖瓣手术且未同期处理主动脉瓣的患者,随访至术后中位81.2个月。主要终点为进展至重度主动脉瓣功能障碍或需后续主动脉瓣置换,10年累积发生率在基线主动脉瓣轻度及以上功能障碍者中为7.4%±2.5%,显著高于无或微量者的0.4%±0.3%。主动脉瓣峰值压差、主动脉瓣反流程度和时间与终点事件显著相关。
要点
- 风湿性二尖瓣术后重度主动脉瓣功能障碍或需换瓣不常见,总体发生率为0.33%/患者年。
- 基线主动脉瓣轻度及以上功能障碍者10年累积发生率达7.4%±2.5%,需密切随访。
- 主动脉瓣峰值压差、反流程度和随访时间与终点事件独立相关。
核心结论
- 风湿性二尖瓣术后进展至重度主动脉瓣功能障碍或需主动脉瓣置换不常见,但基线存在轻度及以上主动脉瓣功能障碍者事件相对常见。
研究设计与样本
- 回顾性队列研究,纳入1997至2015年1155例连续接受风湿性二尖瓣手术且未同期行主动脉瓣手术的患者,年龄52.0±12.9岁,女性807例。
主要发现
- 随访期间26例(0.33%/患者年)达到主要终点。
- 10年累积发生率在基线主动脉瓣无或微量功能障碍者为0.4%±0.3%,在轻度及以上者为7.4%±2.5%(P < .01)。
- 多变量分析显示主动脉瓣峰值压差(OR 1.14,95%CI 1.10-1.20)、主动脉瓣反流程度(轻度 vs 无:OR 3.26,95%CI 1.15-9.23)和时间(OR 1.30,95%CI 1.19-1.41)与主要终点显著相关。
关键数值与推荐
- 基线主动脉瓣严重程度:无至微量880例(76.2%),轻度256例(22.2%),中度19例(1.6%)。
- 主要终点为进展至重度主动脉瓣功能障碍或需后续主动脉瓣置换的复合终点。
- 随访超声评估1062例(91.9%),中位术后81.2个月(四分位距37.3-132.1个月)。
临床怎么用
- 风湿性二尖瓣手术时应评估基线主动脉瓣功能,对轻度及以上功能障碍者加强术后超声随访。
- 关注主动脉瓣峰值压差和反流程度,以识别进展至重度功能障碍的高风险患者。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Deterioration of the native aortic valve function by a late progression of rheumatic disease is not infrequent in patients who underwent rheumatic mitral valve surgery; however, this phenomenon has not been clearly quantified. METHODS: A total of 1155 consecutive patients (age 52.0 ± 12.9 years; 807 female) who underwent rheumatic mitral valve surgery without concomitant aortic valve surgery from 1997 to 2015 were enrolled. The primary end point was the composite of progression to severe aortic valve dysfunction or a requirement of subsequent aortic valve replacements during follow-up. To determine the risk factors of the primary outcome, we performed the generalized linear mixed model. RESULTS: The baseline severities of aortic valve were none to trivial in 880 patients (76.2%), mild in 256 patients (22.2%), and moderate in 19 patients (1.6%). The latest 1062 echocardiographic assessments (91.9%; median, 81.2 postoperative months; interquartile range, 37.3-132.1 months) demonstrated 26 cases (0.33%/patient-year) meeting the primary end point during follow-up. Cumulative incidence of the primary end point at 10 years was 0.4% ± 0.3% and 7.4% ± 2.5% depending on the presence of mild or greater aortic valve dysfunction at baseline (P < .01). In multivariable analyses, aortic valve peak pressure gradient (odds ratio, 1.14; 95% confidence interval, 1.10-1.20), aortic regurgitation degree (mild over none: odds ratio, 3.26; 95% confidence interval, 1.15-9.23), and time (odds ratio, 1.30; 95% confidence interval 1.19-1.41) were significantly associated with the occurrence of the primary end point. CONCLUSIONS: Progression of severe aortic valve dysfunction and the need for aortic valve replacement are uncommon in patients undergoing rheumatic mitral valve surgery. However, such events were relatively common among those with mild or greater aortic valve dysfunction at the time of mitral valve surgery.
引用
- Kim HR, Kim WK, Kim HJ, et al. The fate of aortic valve after rheumatic mitral valve surgery. J Thorac Cardiovasc Surg. 2021. PMID: 33867129. doi:10.1016/j.jtcvs.2021.03.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。